Sign In  |  Register  |  About Corte Madera  |  Contact Us

Corte Madera, CA
September 01, 2020 10:27am
7-Day Forecast | Traffic

  • Search Hotels in Corte Madera

  • CHECK-IN:
  • CHECK-OUT:
  • ROOMS:
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Eli Lilly (NY: LLY )

829.74 UNCHANGED
Streaming Delayed Price Updated: 7:00 PM EDT, Oct 31, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Eli Lilly

< Previous 1 2
...
24 25 26 27 28 29 30 31 32
...
99 100 Next >
The Must-Watch List: 3 Stocks to Snap Up as Soon as They Hit Bargain Territory
These three companies could soon be the next bargain stocks to buy as the market adjusts to their developing situations. 
Via InvestorPlace
Healthcare And Biotech Investing 101: What You Need To Know.
Healthcare as a sector represents only about 12% of the S&P 500. If you want to overweight healthcare as a sector you need to add equities. Healthcare is usually a defensive sector because of... 
Via Talk Markets
Topics Stocks
Exposures US Equities
1 No-Brainer Growth Stock to Buy and Hold
It's hard to bet against this high-flying stock. 
Via The Motley Fool
MarketBeat Week in Review – 5/6 - 5/10
Sell in May, then go away got pushed to the side this week, but the bearish sentiment could return when investors get the latest read on inflation next week. 
Via MarketBeat
Topics Economy
Exposures Interest Rates
Want Decades of Passive Income? 3 Stocks to Buy Now and Hold Forever.
These pharmaceutical companies are top-notch dividend growth stocks for the future. 
Via The Motley Fool
This Is What Whales Are Betting On Eli Lilly and Co
Via Benzinga
$100 Invested In This Stock 15 Years Ago Would Be Worth $2,200 Today
Via Benzinga
This Is What Whales Are Betting On Eli Lilly and Co
Via Benzinga
SPDR ETF Report For Friday, May 10
In this video, Ira Epstein reviews the day's trading in various SPDR-ETF markets for the trading day that ended, Friday, May 10. 
Via Talk Markets
Topics ETFs
Highest And Lowest Price To Sales (P/S) Ratios
In the S&P 1500 there are just under 1,175 stocks that have positive next-year EPS estimates and trailing 12-month revenues of more than $1 billion. 
Via Talk Markets
Topics Stocks
Exposures US Equities
3 Biotech Stocks to Sell in May Before They Crash & Burn
Discover essential insights on biotech stocks to sell in May to navigate market volatility and safeguard your investment portfolio. 
Via InvestorPlace
Can Weight Loss Companies Fuel Gains In Your Stock Portfolio?
Analysts predict the weight loss drug market could reach $100 billion by the end of the decade, with millions of patients potentially using these medications. However, challenges remain. 
Via Talk Markets
7 Weight Loss Drug Stocks Poised for Explosive Growth by 2025
The second wave of the weight loss drug stock boom is underway and investors should heed the signs the market is serving. 
Via InvestorPlace
This 1 Simple ETF Could Turn $100 a Month Into $93,200
Turn small investments into big returns with this surprisingly simple strategy -- and a hands-off ETF investment for the ages. 
Via The Motley Fool
Topics ETFs
Google DeepMind Develops Latest AI Model To Aid Scientists In Fighting Disease
Google DeepMind reveals its AlphaFold 3, which specializes in molecular predictions for proteins, DNA, RNA, and drug molecules. 
Via Benzinga
Topics Artificial Intelligence
Exposures Artificial Intelligence
Actinium Pharmaceuticals (NYSE: ATNM): A Prime Target in a Wave of Radiopharmaceutical Mergers and Acquisitions
Via AB Newswire
Hedge Fund Legend Druckenmiller Shares His Top Secrets For 30% Returns
Legendary hedge fund manager Stanley Druckenmiller made right bets at the right time. He came to fame for earning Soros $10B overnight. Successful hedge fund, Duquesne Capital, boasts $10B fortune. 
Via Benzinga
Biotech Breakthroughs: 7 Stocks Driving the Next Wave in Healthcare
Investors concerned about broader market undulations may want to consider the resilience narrative of these biotech stocks to buy. 
Via InvestorPlace
10 Health Care Stocks With Whale Alerts In Today's Session
Via Benzinga
What About Eli Lilly's Drug For Early Alzheimer's? FDA Panel To Discuss Next Month
FDA's advisory committee meeting on June 10, 2024, discussing Eli Lilly's donanemab for early Alzheimer's. 
Via Benzinga
Exposures Product Safety
Sigyn Therapeutics Discloses Publication of "Sigyn Therapy, an Emerging Candidate to Address Endotoxemia, Sepsis, and Drug-Resistant Viral & Bacterial Infections"
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations. 
Via NewMediaWire
Exposures COVID-19
Sigyn Therapeutics Discloses Publication of "Sigyn Therapy, an Emerging Candidate to Address Endotoxemia, Sepsis, and Drug-Resistant Viral &amp; Bacterial Infections"
SAN DIEGO, CA - (NewMediaWire) - May 07, 2024 - Sigyn Therapeutics, Inc. (“Sigyn Therapeutics”, “Sigyn” or the “Company”) (OTCQB: “SIGY”), a development-stage medical technology company, announced... 
Via TheNewswire.com
Exposures COVID-19
Why Eli Lilly Stock Jumped by 4% Today
The company's payout is far from the only reason investors like the stock these days, but it certainly helps. 
Via The Motley Fool
3 Biotech Stocks to Double Your Money in the Next 24 Months
The biotech sector offers significant potential for growth. These 3 biotech stocks to double your money are noteworthy candidates. 
Via InvestorPlace
Eli Lilly Gains on the GLP-1 Weight Loss Phenomenon
Eli Lilly stock continues to move higher after the company reported continuing momentum for its flagship GLP-1 weight loss drugs 
Via MarketBeat
2 Top Stocks That Could Make You Richer in 2024
Here are a couple of great ideas on where to invest your money today. 
Via The Motley Fool
3 Super-Safe Dividend Stocks That Have Been Making Recurring Payments for 130+ Years
These stocks have rock-solid businesses and they have impressive track records for paying dividends. 
Via The Motley Fool
3 No-Brainer Stocks to Buy in May
These great stocks are great picks for investors as spring winds down. 
Via The Motley Fool
Move Over, Mounjaro. Eli Lilly Has Another Blockbuster in the Making
Eli Lilly has made inroads in the red-hot weight-loss market thanks to its diabetes blockbuster, Mounjaro. 
Via The Motley Fool
Eli Lilly Raised Its Outlook. Is the Stock a Buy Now?
The anti-obesity medication stock is way up, and there could be more fuel in the tank. 
Via The Motley Fool
< Previous 1 2
...
24 25 26 27 28 29 30 31 32
...
99 100 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
 
 
About Us | Contact Us | Privacy Policy | User Agreement | Advertise With Us | Site Map
Copyright © 2010-2020 CorteMadera.com & California Media Partners, LLC. All rights reserved.